Effect of Linagliptin on Incretin-axis and Glycaemic Variability in T1DM.

Conclusions: Linagliptin is not effective in reducing HbA1C and glycaemic variability in relatively well controlled T1DM patients. PMID: 31325257 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31325257?dopt=Abstract

Source: Journal of the Association of Physicians of India - July 22, 2019 Category: General Medicine Tags: J Assoc Physicians India Source Type: research